Burden of illness in patients with treatment refractory myasthenia gravis
| Autor: | Ryan Wolbeck, Audra Boscoe, Nicholas Silvestri, Jonathan C Johnson, Nicole M. Engel-Nitz |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Health plan
medicine.medical_specialty Exacerbation Physiology business.industry Treatment refractory Myasthenic crisis medicine.disease Myasthenia gravis Disease course 03 medical and health sciences Cellular and Molecular Neuroscience 0302 clinical medicine Refractory Physiology (medical) Internal medicine Medicine In patient 030212 general & internal medicine Neurology (clinical) business 030217 neurology & neurosurgery |
| Zdroj: | Muscle & Nerve. 58:99-105 |
| ISSN: | 0148-639X |
| DOI: | 10.1002/mus.26114 |
| Popis: | INTRODUCTION This study assessed the clinical burden of refractory myasthenia gravis (MG), relative to nonrefractory MG. METHODS Rates of myasthenic crises, exacerbations, inpatient hospitalizations, and emergency room (ER) visits over a 1-year period were measured for 403 refractory, 3,811 nonrefractory, and 403 non-MG control patients from two administrative health plan databases. RESULTS Compared with nonrefractory patients, a significantly greater percentage of refractory patients had at least one myasthenic crisis (21.3% vs. 6.1%; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text